Market cap
$4.1b
End-of-day close multiplied by current shares on issue.
Revenue and EBITDA both grew, but a heavier debt load drove PBT to NZ$2m and NPAT to a NZ$5m loss while the dividend was lifted.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$4.1b
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
170.48x
Recent market cap compared with trailing earnings.
EPS
0.06
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
10.15x
Enterprise value compared with recent EBITDA.
P/FCF
9.19x
Market cap compared with recent free cash flow.
P/B
9.52x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
6.2%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
HY25 vs HY24
Revenue
$500m
+4.0% ↑ vs $481m
EBITDA
$346m
+5.8% ↑ vs $327m
Net profit after tax
−$5m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
$257m
-4.8% ↓ vs $270m
Interim dividend per share
23.0c
+70.4% ↑ vs 13.5c
Profit before tax
$2m
-94.6% ↓ vs $37m
Cash and cash equivalents
$83m
+418.8% ↑ vs $16m
Total assets
$6.1b
+0.7% ↑ vs $6b
What changed
Revenue grew 4.0% to NZ$500.0m, EBITDA rose to NZ$346.0m, and operating profit increased 9.9% to NZ$111.0m. Profit before tax then collapsed 94.6% to NZ$2.0m from NZ$37.0m, and NPAT swung to a NZ$5.0m loss from a NZ$26.0m profit (-119.2%).
The wedge between operating profit and PBT is the financing line. Gross borrowings rose 33.7% to NZ$2.9b and net debt/EBITDA stepped up to 8.1x from 6.6x, so the roughly NZ$10m of operating-profit improvement was more than absorbed by a higher interest charge.
Cash quality moved the other way: capex fell 19.1% to NZ$199.0m and pre-lease free cash flow more than doubled to NZ$58.0m, well above the company's historical baseline mean of -NZ$7.0m (range -NZ$45.0m to NZ$24.0m). The interim dividend was lifted to 23.0 cents from 13.5 cents.
What matters
Operating profit growth of 9.9% was fully consumed below the line, and PBT margin compressed to 0.4%. With net debt/EBITDA at 8.1x and gross borrowings up NZ$727m year-on-year, the operating improvement Chorus is delivering is not currently reaching the bottom line for shareholders.
The tax line distorted the headline NPAT print. The effective tax rate of 350.0% versus 29.7% in the prior period is well above the historical range and turns a small NZ$2.0m PBT into a NZ$5.0m reported loss; PBT is the cleaner read on the period, and PBT itself is weak. This matters because the loss headline overstates the period's deterioration relative to underlying operations, while PBT understates how much of the operating gain is being lost to financing.
Cash generation improved even as earnings fell. Pre-lease FCF of NZ$58.0m sits above the supplied historical range, driven mainly by lower capex (39.8% of revenue versus 51.1%) rather than higher operating cash flow, which actually fell 4.8% to NZ$257.0m. The implication is that current free cash strength is partly a build-cycle effect, not a step-change in earnings power.
Expectations
The HY24/FY24 split implies a second-half-weighted year: HY24 contributed 47.6% of FY24 revenue and 46.7% of FY24 EBITDA, and FY24 NPAT was already a NZ$9.0m loss. On that pattern, the HY25 NZ$5.0m loss is consistent with another full-year loss unless interest costs ease or operating leverage from fibre revenue accelerates in the second half.
The release does not support any read on whether financing costs have peaked, which is the variable that matters most for FY25 PBT and dividend coverage.
Quality of result
The cash result is balance-sheet-assisted rather than purely earnings-driven. Pre-lease FCF improvement of NZ$34m came predominantly from a NZ$47m capex reduction, not operating cash, so durability depends on whether current capex intensity is a sustained step-down or a timing trough. The dividend lift to 23.0 cents is hard to reconcile with a NZ$5.0m statutory loss and 8.1x leverage; on the prior comparable, the payout ratio versus NPAT was already 106.6%, and the current period cannot be covered from reported earnings at all. ROE moved to -0.8% from 1.8%, a direct read-through of the financing pressure.
Unresolved
This briefing cannot assess whether the financing cost step-up reflects rate resets, drawn debt for capex, or both, because the release excerpts supplied do not break out interest expense drivers.
Chat
Ask follow-up questions about Chorus's HY25 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
1. Chorus media release HY25
HY25 / media release2. Investor Presentation
HY25 / results presentation3. Chorus HY25 Management Commentary and Financial Statements
HY25 / financial report4. HY25 Results Announcement
HY25 / results announcementHalf year results details: Tuesday 27 February 2024
HY24 / financial reportAnnual Report - FY24
FY24 / financial reportMedia Release - FY24 results
FY24 / media releaseNZX Financial Results Announcement - FY24
FY24 / results announcementChorus investor day – speaker details and webcast link
HY25 / commentaryChorus Investor Day 2024 - cover
HY25 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Leverage and balance-sheet risk
Net debt / EBITDA is 8.10x, +1.50x versus the prior comparable period.
Cash conversion quality
This result converted 74.3% of EBITDA to operating cash flow, -8.3pp versus the prior comparable period.
Earnings quality and statutory distortions
This result includes a statutory earnings-quality distortion flag.
Revenue growth context
Revenue growth was 4.0% for this reporting period.
Get the next Chorus briefing and related NZX reporting-season updates by email.